Abstract
Sodium valproate (VPA) is currently one of the major antiepileptic drugs and has been reported to impair the induction of long-term potentiation (LTP) in rat hippocampal. However, there are discrepancies when used at therapeutic dose and few researches to study the effects of VPA on the maintenance of LTP. Here we investigated the effects of VPA at therapeutic concentration on two LTP phases: induction and maintenance in CA1 region. We found (1) VPA inhibited field excitatory postsynaptic potentials (fEPSPs) without modifying paired-pulse facilitation (PPF) solely occured presynaptically as a form of synaptic plasticity. (2) Pretreatment with VPA before high-frequency stimulation (HFS) decreased the fEPSPs slope. (3) There were no significant changes in fEPSPs slope with VPA applied in maintenance phase of LTP. These results indicate that VPA inhibited the induction of LTP postsynaptically without modifying presynaptic neurotransmitter release and had no significant influence on the two maintenance phase of LTP.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biochemical and Biophysical Research Communications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
